Vanicon 1,25 mg/ 2,5 mg/ 5 mg/ 10 mg CAPSULES
PDF Leaflet Revision Date: 06 December 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Mild to moderate hypertension and heart failure post-myocardial infarction.
Dosage (summary)
Initial: 2.5 mg once daily, max 10 mg/day; adjust based on response.
Onset of Action / Duration
Onset: 1-2 hours, Duration: 24 hours
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended; can cause fetal harm.
Key Drug Interactions
- Potassium sparing diuretics
- Lithium
- NSAIDs
Contraindications
- Angioedema history
- Severe renal impairment
- Pregnancy
- Bilateral renal artery stenosis
Common side effects
- Dizziness
- Dry cough
- Nausea
- Fatigue
Counselling Points
- Take with water after meals
- Monitor blood pressure
- Avoid potassium supplements
Serious warnings
- Risk of severe hypotension
- Angioedema risk
- Monitor renal function
Important Disclaimer
The Vanicon 1,25 mg/ 2,5 mg/ 5 mg/ 10 mg CAPSULES professional information leaflet below is the property of Aurogen South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
